Kevin R. Sayer, Executive Chair at DEXCOM INC (DXCM), sold 26,756 shares at $89.71 ($2.4M) on 2026-08-20, disclosed to the SEC on 2026-08-24.
Scheduled sale ($2.4M) by Executive Chair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.71 | 19,308 | $1.7M | 71.9% |
| 2 | $90.78 | 7,351 | $667K | 27.7% |
| 3 | $91.41 | 97 | $9K | 0.4% |
| Total | $90.01 avg | 26,756 | $2.4M | 100% |
| Filing → |
| DXCM | SELL | 2026-05-26 | $1.9M | — | Filing → |
| DXCM | SELL | 2025-03-14 | $4.6M | — | Filing → |
| DXCM | SELL | 2025-01-30 | $5.8M | — | Filing → |